|
|
In Editorials
Interview with Dr. Paul Thompson on the Role of Coenzyme Q10 (CoQ10) in Statin-Associated Myopathy
Paul D. Thompson, MD Although serious statin-associated myopathy is rare, muscle-related complaints are generally held to be the most common and clinically significant adverse effects of statin therapy. The mechanism by which statins may affect muscle is unknown, and a number of explanations have been proposed. One theory that has attracted wide interest relates statin-associated muscle complaints to depletion of coenzyme Q10 (CoQ10). The role of CoQ10 in statin-associated myopathy is the subject of a recently published systematic review by Leo Marcoff and APOLLO Steering Committee member Paul D. Thompson.1 In this interview, Dr. Thompson discusses the prevalence of statin-related muscle complaints, theories about their causation, and the conclusions of his and Dr. Marcoff’s review of the evidence on the role of CoQ10.
|
More >>
In Q & A
More >>
Clinical Pearl
More >>
Slide Library
More >>
|
|
-
EPC boost may underlie post-AMI statin benefits
Thursday, November 20, 2008 - Results from a small, exploratory study show that intensive statin treatment following acute myocardial infarction increases the concentration of circulating endothelial progenitor cells, but does not appear to significantly improve left ventricular function.
-
Serum lipids useful indicator of malnutrition and inflammation in the elderly
Thursday, November 20, 2008 - Measurements of serum lipids are useful markers of malnutrition and inflammation in elderly patients, show results published in the journal Nutrition.
-
Beneficial effect alcohol on lipids offset by increased BP in heavy drinkers
Thursday, November 20, 2008 - The beneficial effect of alcohol consumption on serum lipids is offset by increases in blood pressure in heavy drinkers, resulting in an overall increase in estimated 10-year coronary artery disease risk, report researchers.
-
Pulse pressure strongly predicts cardiac death in women
Thursday, November 20, 2008 - In women with suspected cardiovascular disease, brachial pulse pressure is a stronger predictor of poor outcome than other blood pressure components, study results demonstrate.
-
Increased heart rate ‘not an independent CV risk factor’
Thursday, November 20, 2008 - Increased heart rate is a marker for increased cardiovascular mortality rather than an independent cardiovascular risk factor, Norwegian researchers believe.
-
ICD algorithm detects lead fracture, prevents inappropriate shocks
Thursday, November 20, 2008 - Researchers have developed a downloadable algorithm to reduce inappropriate shocks in patients with implantable cardioverter-defibrillators.
©
Copyright Current Medicine Group Ltd.
The
Steering Committee
|
The
CVspectrum Steering Committee members direct and develop the content of the CVspectrum
educational initiative
|
- Antonio M. Gotto, Jr., MD, DPhil
Steering Committee Chair
- Christie M. Ballantyne, MD
- Michael B. Clearfield, DO, FACOI
- Michael H. Davidson, MD, FACC, FACP
- Keith C. Ferdinand, MD, FACC
- Robert M. Guthrie, MD
- D. Roger Illingworth, MD, PhD
- Pamela Kushner, MA, MD, FAAFP
- Peter Libby, MD
|
|
|
- Joseph A. Lieberman III, MD, MPH
- MacRae F. Linton, MD
- Carol M. Mason, ARNP, FAHA
- Dervilla M. McCann, MD, FACC
- James M. McKenney, PharmD
- Paul M. Ridker, MD, MPH, FACC, FAHA
- Jeffrey G. Shanes, MD, FACC, FACP, FSCA, FAHA
- Paul D. Thompson, MD
- Peter P. Tóth, MD, PhD, FAAFP, FAHA, FACC
|
|
|
|